-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How to Evaluate the Patient with a Suspected Mast Cell Disorder and How/When to Manage Symptoms

Program: Education Program
Session: Anxiety Provoking Consultations: Mast Cells and Eosinophils
Hematology Disease Topics & Pathways:
adult, drug development, pediatric, Diseases, Therapies, Study Population, Human
Saturday, December 10, 2022, 4:00 PM-5:15 PM

Cem Akin, MD, PhD

University of Michigan, Ann Arbor, MI

Disclosures: Akin: Novartis: Consultancy; Cogent: Consultancy, Research Funding; Blueprint Medicines Corporation: Consultancy, Research Funding.

Previous Presentation | Next Presentation >>